ATP5PF
ATP synthase peripheral stalk subunit F6, mitochondrial
Also known as: ATP5, ATP5A, ATP5J, ATP5J_HUMAN, ATPM, CF6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18859
- Gene
- ATP5PF
- Ensembl
- ENSG00000154723
- Chromosome
- 21
- Canonical length
- 108 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria,Flagellar centriole,End piece
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
Mitochondrial ATP synthase catalyzes ATP synthesis, utilizing an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. It is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel. The F1 complex consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled in a ratio of 3 alpha, 3 beta, and a single representative of the other 3. The Fo complex has nine subunits (a, b, c, d, e, f, g, F6 and 8). This gene encodes the F6 subunit of the Fo complex. The F6 subunit is required for F1 and Fo interactions. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. This gene has 1 or more pseudogenes. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
108 residues, UniProt reviewed canonical sequence.
>P18859|ATP5PF
1 MILQRLFRFS SVIRSAVSVH LRRNIGVTAV AFNKELDPIQ KLFVDKIREY KSKRQTSGGP
61 VDASSEYQQE LERELFKLKQ MFGNADMNTF PTFKFEDPKF EVIEKPQALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5PF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 1,487 nTPM
Expression across tissuesHPA
Tissue
- tongue: 1,487 nTPM
- heart muscle: 1,181 nTPM
- skeletal muscle: 1,089 nTPM
- liver: 704 nTPM
- choroid plexus: 479 nTPM
- kidney: 454 nTPM
Single-cell type
- parietal cells: 2,636 nCPM
- hepatocytes: 1,869 nCPM
- esophageal suprabasal cells: 1,307 nCPM
- esophageal basal cells: 962 nCPM
- colonocytes: 954 nCPM
- esophageal apical cells: 939 nCPM
Immune cell
- total PBMC: 662 nTPM
- myeloid DC: 533 nTPM
- T-reg: 522 nTPM
- non-classical monocyte: 509 nTPM
- plasmacytoid DC: 506 nTPM
- intermediate monocyte: 489 nTPM
Brain region
- choroid plexus: 129 nTPM
- hypothalamus: 108 nTPM
- cerebral cortex: 107 nTPM
- cerebellum: 100 nTPM
- thalamus: 95 nTPM
- medulla oblongata: 93 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5PF.
Disease | ImmuneIEDB
Conditions an epitope on ATP5PF was assayed in.
- sarcoidosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- -0.35
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- proton motive force-driven ATP synthesis
- proton motive force-driven mitochondrial ATP synthesis
- substantia nigra development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATP synthase-coupling factor 6, mitochondrial
- ATP synthase-coupling factor 6 superfamily, mitochondrial
- Mitochondrial ATP synthase coupling factor 6
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5PF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5PF as an antibody target. Whether an autoantibody or antibody against ATP5PF could matter depends on whether native ATP5PF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5PF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5PF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...